Detalhe da pesquisa
1.
Decision-Making among Experts in Advanced Hodgkin Lymphoma.
Oncology
; 101(3): 159-165, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36103806
2.
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.
Blood
; 134(4): 353-362, 2019 07 25.
Artigo
Inglês
| MEDLINE | ID: mdl-31101627
3.
Improved quality of colon cancer surveillance after implementation of a personalized surveillance schedule.
J Surg Oncol
; 122(3): 529-537, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32410263
4.
A long-term retrospective observational study at a medium-sized medical oncology service in Switzerland: comparison of overall survival with a national cohort and adherence to treatment guidelines.
Swiss Med Wkly
; 153: 40091, 2023 07 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37459836
5.
The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study.
Eur Urol Open Sci
; 50: 57-60, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36874175
6.
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.
Haematologica
; 97(7): 1085-91, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22315486
7.
Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses.
Eur Urol Open Sci
; 40: 16-18, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35515270
8.
Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial.
Blood Adv
; 4(23): 5951-5957, 2020 12 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33275769
9.
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.
Lancet Oncol
; 9(5): 435-44, 2008 May.
Artigo
Inglês
| MEDLINE | ID: mdl-18400558
10.
Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial).
Cancers (Basel)
; 11(8)2019 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31374981
11.
Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Swiss Med Wkly
; 148: w14640, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30044478
12.
Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma.
J Thorac Oncol
; 13(11): 1784-1791, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30142389
13.
Enzalutamide in Patients With Castration-Resistant Prostate Cancer Progressing After Docetaxel: Retrospective Analysis of the Swiss Enzalutamide Named Patient Program.
Clin Genitourin Cancer
; 15(3): e315-e323, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27450512
14.
Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03.
J Clin Oncol
; 34(5): 495-500, 2016 Feb 10.
Artigo
Inglês
| MEDLINE | ID: mdl-26712227
15.
Correction to: Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Swiss Med Wkly
; 148: w14674, 2018 08 27.
Artigo
Inglês
| MEDLINE | ID: mdl-30182362
16.
Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06).
J Clin Oncol
; 29(6): 626-31, 2011 Feb 20.
Artigo
Inglês
| MEDLINE | ID: mdl-21205757
17.
Exemestane seems to stimulate tumour growth in men with prostate carcinoma.
Eur J Cancer
; 39(14): 2111-2, 2003 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-12957469
18.
Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research.
J Clin Oncol
; 26(22): 3702-8, 2008 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18669455
19.
Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001.
J Clin Oncol
; 26(22): 3695-701, 2008 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18669454
20.
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.
J Clin Oncol
; 25(16): 2212-7, 2007 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17538165